ALIMERA SCIENCES INC Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alimera Sciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Alimera Sciences Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$77K, a 93.6% increase year-over-year.
  • Alimera Sciences Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $199K.
  • Alimera Sciences Inc annual Operating Income (Loss) for 2023 was -$1.93M, a 83.4% increase from 2022.
  • Alimera Sciences Inc annual Operating Income (Loss) for 2022 was -$11.6M, a 5691% decline from 2021.
  • Alimera Sciences Inc annual Operating Income (Loss) for 2021 was -$201K, a 59.9% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $199K -$77K +$1.13M +93.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$932K -$2.3M +$1M +30.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$1.93M $724K +$2.83M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$4.76M $1.85M +$5.27M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$10M -$1.21M +$766K +38.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$10.8M -$3.3M +$845K +20.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$11.6M -$2.11M +$644K +23.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$12.3M -$3.41M -$1.39M -68.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$10.9M -$1.97M -$8.98M -128% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$1.92M -$4.15M -$1.72M -70.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$201K -$2.75M -$2.93M -1691% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.72M -$2.02M -$2.43M -597% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $5.15M $7M +$8.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$3.15M -$2.43M -$2.65M -1215% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$501K $173K -$1.25M -87.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $753K $407K +$2.12M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$1.37M -$1.3M +$2.29M +63.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$3.66M $218K +$1.61M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$5.27M $1.43M +$1.36M +1882% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-05
Q3 2019 -$6.63M -$1.72M +$479K +21.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$7.11M -$3.59M -$812K -29.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$6.3M -$1.4M +$3.37M +70.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$9.67M $72K +$5.81M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$15.5M -$2.2M +$1.63M +42.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$17.1M -$2.78M -$1.4M -102% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$15.7M -$4.77M +$742K +13.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$16.5M -$5.74M -$373K -6.95% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-02
Q3 2017 -$16.1M -$3.83M +$3.42M +47.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$19.5M -$1.38M +$5.07M +78.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$24.6M -$5.51M +$3.28M +37.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$27.8M -$5.37M +$4.4M +45% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-02
Q3 2016 -$32.2M -$7.24M +$1.2M +14.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-02
Q2 2016 -$33.4M -$6.45M +$3.35M +34.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-02
Q1 2016 -$36.8M -$8.79M +$2.2M +20% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-02
Q4 2015 -$39M -$9.76M +$1.16M +10.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$40.2M -$8.44M +$181K +2.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$40.3M -$9.8M -$3.84M -64.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$36.5M -$11M -$3.55M -47.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
Q4 2014 -$32.9M -$10.9M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$8.63M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$5.96M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$7.44M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.